Related Experiment Videos
Active valvulitis associated with chronic rheumatic valvular disease and active myocarditis
Circulation
|January 1, 1978
Summary
Chronic rheumatic valvular disease stems from recurrent inflammation, often affecting heart valves without obvious symptoms. This study highlights active valvulitis in most patients with rheumatic heart disease.
Area of Science:
- Cardiology
- Rheumatology
- Pathology
Background:
- Chronic rheumatic valvular disease is a significant cause of cardiac morbidity.
- Active rheumatic myocarditis, characterized by Aschoff bodies, is a key pathological feature.
- Understanding the inflammatory process in valvular disease is crucial for management.
Purpose of the Study:
- To evaluate the incidence, distribution, and severity of active inflammation in heart valves of patients with chronic rheumatic valvular disease.
- To correlate histological findings with clinical evidence of active rheumatic fever.
- To investigate the role of recurrent inflammation in the pathogenesis of fibrosing rheumatic valvular disease.
Main Methods:
- Histological examination of heart valves from ten patients (aged 15-40) with chronic rheumatic valvular disease and confirmed Aschoff bodies.
- Assessment of active inflammation in leaflets and annuli of aortic, mitral, tricuspid, and pulmonary valves.
- Evaluation of active rheumatic lesions in the left atrial appendage.
Main Results:
- Active rheumatic valvulitis was present in all ten patients, affecting at least one valve.
- 83% of individual valves showed active inflammation; aortic (100%) and mitral (86%) valves were most frequently involved.
- Mitral and tricuspid valves exhibited the most severe inflammation when affected. Active lesions were consistently found in the left atrial appendage.
Conclusions:
- The high incidence of active valvulitis supports the theory that chronic fibrosing rheumatic valvular disease results from recurrent inflammatory episodes.
- Active inflammation of heart valves can occur even without clinical signs of active rheumatic fever.
- These findings underscore the importance of recognizing subclinical inflammation in rheumatic heart disease progression.